Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

CAMS Oxford Institute Network Day Held at Richard Doll Building on 6 June 2025

The CAMS Oxford Institute (COI) held its 2025 Network Day on 6 June at the Richard Doll Building, bringing together researchers, clinicians, and collaborators for a day of scientific exchange, collaborative reflection, and discussion on the future of translational immunology. The programme featured a rich mix of talks, poster presentations, and networking sessions designed to highlight both established research strengths and emerging voices across the COI community.

Pablo Cespedes’s group won a Partnerships and Impact Award from the NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research)

NC3Rs highlight Pablo’s latest award, Validating human lymphoid organoids and explants as 3Rs methods to reduce and replace animal use in immunology research.

Group Leader, Katherine Bull, COI Principal Investigator, awarded Associate Professor title

We are delighted to celebrate that Katherine Bull, COI Principal Investigator, has been awarded the title of Associate Professor, in recognition of her outstanding contributions to science and teaching.

EMBO Lab Leadership Course for Postdocs Successfully Concludes at Oxford University Careers Service

The EMBO Lab Leadership Course for Postdocs concluded successfully on 13-15 May 2025. A total of 18 postdoctoral researchers participated in the three-day, in-person programme, including six postdocs from the CAMS Oxford Institute (COI).

T cell responses to monkeypox play a part in protecting against infection

A new study, led by researchers at the NDM's CAMS Oxford Institute and the Centre for Human Genetics, TIDU in the MRC Weatherall Institute of Molecular Medicine, the Kennedy Institute and the Dunn School of Pathology, has found that specific T cells could have an impact on the long-term protective responses to future infection.

Professor Andrew McMichael, COI Principal Investigator, elected to the US National Academy of Sciences

The National Academy of Sciences (NAS) in the US just announced the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original research. Election to membership in the NAS is a mark of excellence in science and considered one of the highest honours that a scientist can receive.

Sarah Gilbert, COI Principal Investigator, receives Royal Society of Chemistry Honorary Fellowship

Professor Dame Sarah Gilbert honoured for outstanding contributions to global vaccine research and public health impact.

COI Spatial Profiling Hub receives formal accreditation as a Bruker Academic Partner

We’re pleased to announce that the CAMS Oxford Institute Spatial and Gene Profiling Hub has been formally recognized by Bruker Spatial Biology for its generation of high-quality spatial transcriptomic and proteomic data across its nCounter® and GeoMx® Digital Spatial Profiler platforms.

Matthew Bottomley: The Latest Winner in CRUK’s ‘Research is Beautiful’ Campaign

Research is Beautiful campaign continues to inspire with some fantastic images. Congratulations to Dr Matthew Bottomley of the CAMS Oxford Institute, his image shoes a cutaneous squamous cell carcinoma infiltrating into the dermis.

Researchers develop new method to identify fake Covid-19 vaccines

Researchers at the University of Oxford and their collaborators, including the Serum Institute of India, have developed an innovative method to identify falsified vaccines without opening the vaccine vial.

New funding to create a Lymphoid Organoid and Explant Hub received from NC3Rs

Dr Pablo F. Céspedes, CAMS Oxford Institute Career Development Fellow, has received funding from NC3Rs to establish a lymphoid organoid and explant hub at the University of Oxford.

Adán Pinto-Fernández wins a 2024 OCION Pump Prime Award

Career Development Fellow Adán Pinto-Fernández has won the CRUK-Centre for his project titled Targeting ISGylation to Boost Cancer Antigenicity: A Novel Approach for Cancer Immunotherapy

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.

Novel antibody platform tackles viral mutations

Scientists in the Nuffield Department of Medicine and the Icahn School of Medicine at Mount Sinai have developed an innovative antibody platform aimed at tackling one of the greatest challenges in treating rapidly evolving viruses like SARS-CoV-2: their ability to mutate and evade existing vaccines and therapies.

T-cell aerosol immunisation as path to universal influenza vaccine

In a new study, published in NPJ Vaccines, researchers from the Pandemic Sciences Institute and The Pirbright Institute have generated new evidence supporting the development of a universal influenza vaccine.

Adán Pinto-Fernández Secures Prestigious 2-Year Grant from Boehringer Ingelheim

CAMS Oxford Institute Group Leader and Career Development Fellow, Adán Pinto-Fernández, has been awarded a highly competitive 2-year project grant by Boehringer Ingelheim through their Open Innovation Portal initiative, opnMe.

ORTU awarded £2.8m to study treatment for pleural infection

The Oxford Respiratory Trials Unit (ORTU) at the Nuffield Department of Medicine has been awarded a £2.8 million grant from the National Institute for Health and Care Research Health Technology Assessment (NIHR HTA) to conduct the MIST4 study.

Peijun Zhang elected to European Molecular Biology Organization membership

120 scientists from across Europe and beyond have been elected to the European Molecular Biology Organization (EMBO) membership, an honour that celebrates research excellence and outstanding achievements in the life sciences, including Dr Peijun Zhang from the Nuffield Department of Medicine.

Sepsis patients could get the right treatment faster based on their genes

Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms. New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments and lead to the development of targeted therapies.

Novel data method sheds light on hidden patterns of kidney inflammation

Globally kidney disease is forecast to be the 5th leading cause of death by 2040, and in the UK more than 3 million people are living with the most severe stages of chronic kidney disease. Chronic kidney disease is often due to autoimmune damage to the filtration units of the kidney, known as the glomeruli, which can occur in lupus, a disease which disproportionally affects women and people of non-white ethnicities, groups often underrepresented in research. Treatment options are limited, can have life threatening side-effects and often don’t slow the disease, which can then progress to end stage, requiring dialysis or a kidney transplant.

Load More